KR880001643A - Ischemic vascular disease treatment method - Google Patents
Ischemic vascular disease treatment method Download PDFInfo
- Publication number
- KR880001643A KR880001643A KR1019870006952A KR870006952A KR880001643A KR 880001643 A KR880001643 A KR 880001643A KR 1019870006952 A KR1019870006952 A KR 1019870006952A KR 870006952 A KR870006952 A KR 870006952A KR 880001643 A KR880001643 A KR 880001643A
- Authority
- KR
- South Korea
- Prior art keywords
- carbon atoms
- alkoxy
- alkyl
- compound
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
내용 없음No content
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.
제1도는 KP 3와 플루나리진 농도의 로그의 용혈억제의 백분율과의 상관관계를 나타낸 그래프.1 is a graph showing the correlation between KP 3 and the percentage of hemolytic inhibition of log of flunarizine concentration.
제2도는 칼슘이온이 부가된 적혈구의 엑타사이토메트리 변형지수에 대한 KP 3의 영향을 나타낸 그래프.2 is a graph showing the effect of KP 3 on the ectocytometry modification index of red blood cells added with calcium ion.
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868616047A GB8616047D0 (en) | 1986-07-01 | 1986-07-01 | A 1 4-dihydropyridine derivatives |
GB8616047 | 1986-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR880001643A true KR880001643A (en) | 1988-04-25 |
Family
ID=10600369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870006952A KR880001643A (en) | 1986-07-01 | 1987-07-01 | Ischemic vascular disease treatment method |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS6322519A (en) |
KR (1) | KR880001643A (en) |
AU (1) | AU7491487A (en) |
DE (1) | DE3720509A1 (en) |
DK (1) | DK333587A (en) |
FR (1) | FR2601012A1 (en) |
GB (2) | GB8616047D0 (en) |
IT (1) | IT1216830B (en) |
SE (1) | SE8702697L (en) |
ZA (1) | ZA874768B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4011695A1 (en) * | 1990-04-11 | 1991-10-17 | Bayer Ag | USE OF N-ALKYLATED 1,4-DIHYDROPYRIDE INDICARBOXIC ACID ESTERS AS DRUGS, NEW COMPOUNDS AND METHOD FOR THEIR PREPARATION |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI64938C (en) * | 1977-06-20 | 1984-02-10 | Sandoz Ag | PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC THERAPEUTIC BENSOX A- AND OX BENZOTIADIAZOLYL-1,4-DIHYDROPYRID DERIVATIVES |
-
1986
- 1986-07-01 GB GB868616047A patent/GB8616047D0/en active Pending
-
1987
- 1987-06-20 DE DE19873720509 patent/DE3720509A1/en not_active Withdrawn
- 1987-06-25 IT IT8748101A patent/IT1216830B/en active
- 1987-06-26 FR FR8709111A patent/FR2601012A1/en active Pending
- 1987-06-29 DK DK333587A patent/DK333587A/en not_active Application Discontinuation
- 1987-06-29 GB GB08715219A patent/GB2192132A/en not_active Withdrawn
- 1987-06-29 AU AU74914/87A patent/AU7491487A/en not_active Abandoned
- 1987-06-30 SE SE8702697A patent/SE8702697L/en not_active Application Discontinuation
- 1987-06-30 JP JP62165135A patent/JPS6322519A/en active Pending
- 1987-07-01 KR KR1019870006952A patent/KR880001643A/en not_active Application Discontinuation
- 1987-07-01 ZA ZA874768A patent/ZA874768B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE3720509A1 (en) | 1988-01-28 |
AU7491487A (en) | 1988-01-07 |
JPS6322519A (en) | 1988-01-30 |
IT1216830B (en) | 1990-03-14 |
DK333587D0 (en) | 1987-06-29 |
IT8748101A0 (en) | 1987-06-25 |
ZA874768B (en) | 1989-02-22 |
DK333587A (en) | 1988-01-02 |
GB8616047D0 (en) | 1986-08-06 |
GB2192132A (en) | 1988-01-06 |
SE8702697L (en) | 1988-01-02 |
GB8715219D0 (en) | 1987-08-05 |
FR2601012A1 (en) | 1988-01-08 |
SE8702697D0 (en) | 1987-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9600448A2 (en) | Naphthyl compounds, pharmaceutical compositions containing them, process for producing them, their intermediates and their use | |
KR890011592A (en) | Composition for the treatment of endotracheal ischemia | |
KR880006193A (en) | Piperidine Compounds and Their Preparation and Uses | |
KR900016174A (en) | Naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxide useful as a treatment for hyperglycemia | |
RU94022743A (en) | Amido and carbamido derivatives having antihypercholesteric activity, preparation thereof, and therapeutic use thereof | |
KR890005147A (en) | Peptidyl Heterocycle | |
KR900015718A (en) | Osteoarthritis Treatment | |
KR920019798A (en) | Rapamycin Carbamate | |
KR880009948A (en) | Novel naphthalene derivatives for use as antiallergic and anti-inflammatory agents | |
KR890011596A (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for treating insomnia | |
KR890003691A (en) | Piperidine derivatives and therapeutic prophylaxis for arrhythmias containing them | |
KR900018027A (en) | Piperidine derivatives, preparation method thereof, and pharmaceutical composition containing the same as an active ingredient | |
DE69909782D1 (en) | USE OF BENZOFUROXAN DERIVATIVES FOR TREATING ANGINA PECTORIS | |
KR920004387A (en) | 4-substituted dihydropyrido [4,3-d] pyrimidines as topical anti-inflammatory agents for the treatment of analgesics and skin diseases | |
KR880001643A (en) | Ischemic vascular disease treatment method | |
KR900012903A (en) | Pyrrolidine Compounds and Pharmaceutical Uses | |
KR910011807A (en) | 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-one and its use as antispasmodics | |
KR890006621A (en) | Anti-anxiety | |
KR940013503A (en) | Pharmaceutical compositions for the prevention or treatment of atherosclerosis | |
KR880009944A (en) | Piperazine carboxylic acid, preparation method thereof and pharmaceutical composition containing the same | |
NO173137C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE COMPOUNDS | |
KR890012942A (en) | 5-substituted ornithine derivatives | |
KR880001596A (en) | Dihydropyridine Compound-containing Brain Dysfunction | |
KR890003755A (en) | 7- (2-Methyl-4-aminopyrrolidinyl) naphthyridine and quinoline compounds | |
KR880004810A (en) | Peptic Ulcer Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |